MBX vs. TH, ONC, SCYB, COM, NVH, IGX, APS, COV, SVA, and PDP
Should you be buying Microbix Biosystems stock or one of its competitors? The main competitors of Microbix Biosystems include Theratechnologies (TH), Oncolytics Biotech (ONC), Scythian Biosciences (SCYB), 138267 (COM.TO) (COM), Novoheart (NVH), IntelGenx Technologies (IGX), Aptose Biosciences (APS), Covalon Technologies (COV), Sernova (SVA), and Pediapharm (PDP). These companies are all part of the "biotechnology" industry.
Microbix Biosystems vs. Its Competitors
Theratechnologies (TSE:TH) and Microbix Biosystems (TSE:MBX) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their institutional ownership, risk, dividends, valuation, media sentiment, earnings, analyst recommendations and profitability.
51.2% of Theratechnologies shares are held by institutional investors. Comparatively, 0.4% of Microbix Biosystems shares are held by institutional investors. 1.2% of Theratechnologies shares are held by company insiders. Comparatively, 14.0% of Microbix Biosystems shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.
Microbix Biosystems has lower revenue, but higher earnings than Theratechnologies. Theratechnologies is trading at a lower price-to-earnings ratio than Microbix Biosystems, indicating that it is currently the more affordable of the two stocks.
Theratechnologies has a beta of 1.73, suggesting that its stock price is 73% more volatile than the S&P 500. Comparatively, Microbix Biosystems has a beta of 0.34, suggesting that its stock price is 66% less volatile than the S&P 500.
In the previous week, Theratechnologies and Theratechnologies both had 2 articles in the media. Microbix Biosystems' average media sentiment score of 0.58 beat Theratechnologies' score of 0.37 indicating that Microbix Biosystems is being referred to more favorably in the news media.
Microbix Biosystems has a net margin of 13.86% compared to Theratechnologies' net margin of -3.75%. Theratechnologies' return on equity of 14.30% beat Microbix Biosystems' return on equity.
Summary
Theratechnologies beats Microbix Biosystems on 8 of the 14 factors compared between the two stocks.
Get Microbix Biosystems News Delivered to You Automatically
Sign up to receive the latest news and ratings for MBX and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding MBX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Microbix Biosystems Competitors List
Related Companies and Tools
This page (TSE:MBX) was last updated on 8/2/2025 by MarketBeat.com Staff
Free MBX Stock Alerts